je.st
news
Moberg Pharma Announces Plans to Develop BUPI Through Phase III
2016-03-22 11:47:34| Appliances - Topix.net
The decision follows an evaluation of the complete data set from the recent phase II study for BUPI. BUPI is a patent pending lozenge formulation of bupivacaine for pain management in oral mucositis in cancer patients.
Tags: iii
plans
develop
phase
Category:Consumer Goods and Services